This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Memorial Sloan Kettering Cancer Center, The City University of New York. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,798 
1 out of 618 
1 out of 336 Years Active: 2025
Title: Glennon Valere Bythrow: Innovator in Pharmaceutical Compounds
Introduction
Glennon Valere Bythrow is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating infectious diseases.
Latest Patents
Bythrow holds a patent for "Salicyl-adenosinemonosulfamate analogs and uses thereof." This patent includes compounds of Formula (I) and their pharmaceutically acceptable salts or tautomers. The inventive compounds are designed for the treatment and prevention of infectious diseases, including bacterial infections such as tuberculosis.
Career Highlights
Throughout his career, Glennon Valere Bythrow has worked with prestigious institutions, including Memorial Sloan Kettering Cancer Center and City University of New York. His work has focused on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Bythrow has collaborated with notable colleagues, including Derek Shieh Tan and Lisa Charlotte Standke. Their combined expertise has furthered research and development in the field of pharmaceuticals.
Conclusion
Glennon Valere Bythrow's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to impact the treatment of infectious diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile